Fig. 1
From: Danshao Shugan Granule therapy for non-alcoholic fatty liver disease
![Fig. 1](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12944-022-01689-9/MediaObjects/12944_2022_1689_Fig1_HTML.png)
Flowchart of the study. NAFLD patients were treated with indicated drugs and outcomes were monitored for each regimen. Within the DSSG treated patients, 3 subgroups comprising 30 patients in each group were generated according to TCM specific categories and their intergroup outcomes have been compared